digital globe network Digital transformation has proven highly valuable for the fast-paced and ever-evolving pharmaceutical and life science industries. Digitisation initiatives in pharma focus on enhancing operational efficiency, driving innovation, providing better customer experiences, and improving the quality of products and services. However, many companies struggle to adopt full-scale digital solutions across the value chain due to various challenges, including user adoption, the highly regulated nature of the industry, fragmented legacy systems, heavy technology investment, and lack of data interoperability. Companies that truly scale and implement digitisation will be better positioned to take on the pressures of increasing costs for the industry. According to PwC’s 2023 Emerging Technology Survey , 9 in 10 companies are planning to increase their overall technology budget over the next 12 months. This investment would mean cost optimisation, adherence to stringent regulations, operational excellence, rapid speed-to-market, competitive advantage, product quality, and supply chain efficiency for pharmaceutical companies. However, fostering a highly proficient digital workforce is essential for organisations to achieve these objectives, positioning them at the forefront of delivering cutting-edge healthcare solutions to patients worldwide. Challenges to technology adoption Across the pharmaceutical value chain – from research and development to manufacturing and distribution – […]